|
RXRX
|
Recursion Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
SWAV
|
ShockWave Medical, Inc.
|
US
|
NASDAQ
|
|
TCRX
|
TScan Therapeutics, Inc.
|
US
|
NASDAQ
|
|
TOI
|
The Oncology Institute, Inc.
|
US
|
NASDAQ
|
|
UHS
|
Universal Health Services, Inc.
|
US
|
NYSE
|
|
UHT
|
Universal Health Realty Income Trust
|
US
|
NYSE
|
|
UNH
|
UnitedHealth Group Incorporated
|
US
|
NYSE
|
|
UPC
|
Universe Pharmaceuticals Inc.
|
US
|
NASDAQ
|
|
VERA
|
Vera Therapeutics, Inc.
|
US
|
NASDAQ
|
|
VTRS
|
Viatris Inc.
|
US
|
NASDAQ
|
|
ZCMD
|
Zhongchao Inc.
|
US
|
NASDAQ
|
|
ACL
|
Australian Clinical Labs Limited
|
AU
|
ASX
|
|
AGH
|
Althea Group Holdings Limited
|
AU
|
ASX
|
|
EBO
|
EBOS Group Ltd.
|
AU
|
ASX
|
|
EDU
|
EDU Holdings Limited
|
AU
|
ASX
|
|
EHE
|
Estia Health Ltd
|
AU
|
ASX
|
|
FRE
|
Firebrick Pharma Limited
|
AU
|
ASX
|
|
GLH
|
Global Health Limited
|
AU
|
ASX
|
|
HLA
|
Healthia Limited
|
AU
|
ASX
|
|
HLS
|
Healius Ltd
|
AU
|
ASX
|